[go: up one dir, main page]

EP1514216A4 - PRODUCTION AND SELECTION OF A PROTEIN BANK IN SILICA - Google Patents

PRODUCTION AND SELECTION OF A PROTEIN BANK IN SILICA

Info

Publication number
EP1514216A4
EP1514216A4 EP03755415A EP03755415A EP1514216A4 EP 1514216 A4 EP1514216 A4 EP 1514216A4 EP 03755415 A EP03755415 A EP 03755415A EP 03755415 A EP03755415 A EP 03755415A EP 1514216 A4 EP1514216 A4 EP 1514216A4
Authority
EP
European Patent Office
Prior art keywords
silica
selection
production
protein bank
bank
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03755415A
Other languages
German (de)
French (fr)
Other versions
EP1514216A2 (en
Inventor
Peizhi Luo
Mark Hsieh
Pingyu Zhong
Caili Wang
Yicheng Cao
Shengjiang Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abmaxis Inc
Original Assignee
Abmaxis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/153,176 external-priority patent/US20030022240A1/en
Priority claimed from US10/153,159 external-priority patent/US7117096B2/en
Application filed by Abmaxis Inc filed Critical Abmaxis Inc
Publication of EP1514216A2 publication Critical patent/EP1514216A2/en
Publication of EP1514216A4 publication Critical patent/EP1514216A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/30—Detection of binding sites or motifs
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • G16B35/20—Screening of libraries
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/60—In silico combinatorial chemistry
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/50—Mutagenesis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Biotechnology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Library & Information Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Computing Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP03755415A 2002-05-20 2003-05-20 PRODUCTION AND SELECTION OF A PROTEIN BANK IN SILICA Withdrawn EP1514216A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10/153,176 US20030022240A1 (en) 2001-04-17 2002-05-20 Generation and affinity maturation of antibody library in silico
US10/153,159 US7117096B2 (en) 2001-04-17 2002-05-20 Structure-based selection and affinity maturation of antibody library
US153176 2002-05-20
US153159 2002-05-20
PCT/US2003/016037 WO2003099999A2 (en) 2002-05-20 2003-05-20 Generation and selection of protein library in silico

Publications (2)

Publication Number Publication Date
EP1514216A2 EP1514216A2 (en) 2005-03-16
EP1514216A4 true EP1514216A4 (en) 2010-01-06

Family

ID=29586304

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03755415A Withdrawn EP1514216A4 (en) 2002-05-20 2003-05-20 PRODUCTION AND SELECTION OF A PROTEIN BANK IN SILICA

Country Status (7)

Country Link
EP (1) EP1514216A4 (en)
JP (1) JP2005526518A (en)
CN (1) CN1672160B (en)
AU (1) AU2003248548B2 (en)
CA (1) CA2485732A1 (en)
SG (1) SG135053A1 (en)
WO (1) WO2003099999A2 (en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7667004B2 (en) * 2001-04-17 2010-02-23 Abmaxis, Inc. Humanized antibodies against vascular endothelial growth factor
AU2004202566B2 (en) * 2004-06-11 2011-07-21 Li-Te Chin Method for Producing Human Antibodies with Properties of Agonist, Antagonist, or Inverse Agonist
US8647625B2 (en) 2004-07-26 2014-02-11 Biogen Idec Ma Inc. Anti-CD154 antibodies
DK2343380T3 (en) * 2004-11-16 2019-09-09 Humanigen Inc IMMUNOGLOBULIN VARIABLE REGION CARTRIDGE REPLACEMENT
AU2006220709B2 (en) 2005-03-04 2012-09-06 Biogen Ma Inc. Methods of humanizing immunoglobulin variable regions through rational modification of complementarity determining residues
CA2615615A1 (en) 2005-07-22 2007-02-01 Y's Therapeutics Co., Ltd. Anti-cd26 antibodies and methods of use thereof
NZ591252A (en) * 2006-03-17 2012-06-29 Biogen Idec Inc Methods of designing antibody or antigen binding fragments thereof with substituted non-covarying amino acids
DK2069558T3 (en) * 2006-10-02 2013-08-05 Sea Lane Biotechnologies Llc Design and construction of diverse synthetic peptide and polypeptide libraries
WO2008094547A2 (en) * 2007-01-31 2008-08-07 Jiaan Yang Methods, systems, algorithyms and means for describing the possible conformations of actual and theoretical proteins and for evaluating actual and theoretical proteins with respect to folding, overall shape and structural motifs
JP2012508017A (en) * 2008-11-07 2012-04-05 ファブラス エルエルシー Anti-DLL4 antibody and use thereof
CN102482349B (en) * 2009-06-17 2017-08-25 艾伯维生物医疗股份有限公司 Anti-VEGF antibody and its purposes
EP2488867B1 (en) * 2009-10-14 2020-09-30 Janssen Biotech, Inc. Methods of affinity maturing antibodies
WO2013171810A1 (en) 2012-05-14 2013-11-21 パナソニック株式会社 Method for obtaining heat-resistant antibody-presenting phage
US20140154255A1 (en) 2012-11-30 2014-06-05 Abbvie Biotherapeutics Inc. Anti-vegf antibodies and their uses
RU2695146C2 (en) * 2013-01-31 2019-07-22 Кодексис, Инк. Methods, systems and software for identification of biomolecules with interacting components
CN104805507B (en) * 2014-01-29 2019-01-22 杭州康万达医药科技有限公司 phage display library and its application and preparation method
CN106605228B (en) * 2014-07-07 2019-08-16 耶达研究及发展有限公司 Method for calculating protein design
GB201500464D0 (en) * 2015-01-12 2015-02-25 Crescendo Biolog Ltd Method of producing optimised therapeutic molecules
EP3514181A1 (en) * 2015-02-24 2019-07-24 Academia Sinica A phage-displayed single-chain variable fragment library and antibodies selected therefrom
CN104789555A (en) * 2015-04-29 2015-07-22 江南大学 Method of expressing regulatory element based on evolution gene by synthesizing single-chain DNA library
JP6558754B2 (en) 2015-08-07 2019-08-14 富士通株式会社 Information processing apparatus, index dimension extraction method, and index dimension extraction program
CA2992602A1 (en) 2015-09-23 2017-03-30 Genentech, Inc. Optimized variants of anti-vegf antibodies
CN106290908A (en) * 2016-08-07 2017-01-04 查文娟 A kind of for kidney injury detection test kit
WO2018052131A1 (en) * 2016-09-16 2018-03-22 国立大学法人大阪大学 Immunological entity clustering software
CN106905435B (en) * 2017-03-13 2020-04-10 武汉海沙百得生物技术有限公司 Method for preparing binding protein based on protein A mutant
MA51864A (en) * 2017-04-18 2020-02-26 X Chem Inc METHODS OF IDENTIFICATION OF COMPOUNDS
EP3669018A4 (en) * 2017-08-18 2021-05-26 Nautilus Biotechnology, Inc. Methods of selecting binding reagents
WO2019099882A2 (en) * 2017-11-20 2019-05-23 Nantbio, Inc. mRNA DISPLAY ANTIBODY LIBRARY AND METHODS
CN108304691B (en) * 2018-02-09 2021-05-18 北京矿冶科技集团有限公司 Fragment-based flotation agent molecule design method
CN108491692B (en) * 2018-03-09 2023-07-21 中国科学院生态环境研究中心 A method for constructing antibiotic resistance gene database
CN108763870B (en) * 2018-05-09 2021-08-03 浙江工业大学 A construction method of multi-domain protein Linker
CN109002690B (en) * 2018-06-08 2021-05-18 济南大学 Method for predicting side chain structure of mutant amino acid by constructing CHARMM ROTAMERS force field
CN108959846B (en) * 2018-07-03 2021-09-14 南昌立德生物技术有限公司 Affinity free energy decomposition algorithm for computer-aided pilot medicament optimization design
CN109243526B (en) * 2018-07-12 2021-08-03 浙江工业大学 A protein structure prediction method based on the intersection of specific fragments
CN109086568B (en) * 2018-08-16 2022-03-11 福建工程学院 Computer antibody combination mutation evolution system and method, information data processing terminal
CN109801679B (en) * 2019-01-15 2021-02-02 广州柿宝生物科技有限公司 A Mathematical Sequence Reconstruction Method for Long Chain Molecules
JP7524215B2 (en) * 2019-04-09 2024-07-29 エーテーハー チューリッヒ Systems and methods for classifying antibodies
WO2020246617A1 (en) * 2019-06-07 2020-12-10 中外製薬株式会社 Information processing system, information processing method, program, and method for producing antigen-binding molecule or protein.
CN114340735B (en) * 2019-06-28 2024-11-12 璟尚生物制药公司 Antitumor antagonists composed of mutant TGFβ1-RII extracellular domain and immunoglobulin scaffold
BR112022014422A2 (en) * 2020-01-23 2022-09-13 Massachusetts Inst Technology FUNCTIONAL SCREENING METHODS OF BIOLOGICAL SEQUENCE FRAGMENTS
CN115349128A (en) * 2020-02-13 2022-11-15 齐默尔根公司 Metagenomic libraries and natural product discovery platform
CN111370074B (en) * 2020-02-27 2023-07-07 北京晶泰科技有限公司 Method and device for generating molecular sequence and computing equipment
CN111462815B (en) * 2020-03-27 2023-05-02 上海祥耀生物科技有限责任公司 A method and device for constructing an antibody library
CN112102883B (en) * 2020-08-20 2023-12-08 深圳华大生命科学研究院 Base sequence coding method and system in FASTQ file compression

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002084277A1 (en) * 2001-04-17 2002-10-24 Abmaxis, Inc. Structure-based construction of human antibody library

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3415395A (en) * 1994-08-26 1996-03-22 Eli Lilly And Company Antibody constructs with cdr switched variable regions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002084277A1 (en) * 2001-04-17 2002-10-24 Abmaxis, Inc. Structure-based construction of human antibody library

Also Published As

Publication number Publication date
AU2003248548B2 (en) 2010-03-11
WO2003099999A3 (en) 2004-09-16
WO2003099999A2 (en) 2003-12-04
JP2005526518A (en) 2005-09-08
AU2003248548A1 (en) 2003-12-12
CA2485732A1 (en) 2003-12-04
CN1672160B (en) 2010-06-09
CN1672160A (en) 2005-09-21
EP1514216A2 (en) 2005-03-16
SG135053A1 (en) 2007-09-28

Similar Documents

Publication Publication Date Title
EP1514216A4 (en) PRODUCTION AND SELECTION OF A PROTEIN BANK IN SILICA
EP1495055A4 (en) PRODUCTION OF FUNCTIONAL ANTIBODIES IN FILAMENTOUS FUNGI
EP1581641A4 (en) COMPOSITIONS, SPLICE VARIANTS AND METHODS RELATING TO OVARY SPECIFIC GENES AND PROTEINS
EP1451293A4 (en) NOVEL FUSION PROTEINS SULFURYLASE-LUCIFERASE AND THERMOSTABLE SULFURYLASE
EP1391073A4 (en) USE AND PRODUCTION OF A SESSION KEY IN AN SSL CONNECTION
NO20040246L (en) TACIs and BR3 polypeptides and uses thereof
EP1531851A4 (en) COVALENT CONJUGATES BETWEEN ARTEMISININE-RELATED ENDOPEROXIDES AND IRON-CARRIED PROTEINS AND METHODS OF USE THEREOF
FR14C0007I1 (en) REMODELING AND GLYCOCONJUGATION OF PEPTIDES
EP1713916A4 (en) INSULATED IMRNA MOLECULES OF A HUMAN EMBRYONIC STEM CELL
ATE517855T1 (en) ANTIBODIES TO CHEMOTACTIC MONOCYTE PROTEINS
EP1390741A4 (en) STRUCTURAL CONSTRUCTION OF HUMAN ANTIBODY LIBRARIES
ITMI20000227A0 (en) AMIDES USEFUL IN THE INHIBITION OF IL-8 INDUCED NEUTROPHILE CHEMOTAXY
EP1566999A4 (en) INCREASED PRODUCTION OF PROTEINS AND OIL IN PLANTS BY INTERRUPTION OF THE PHENYLPROPANOIDE PATHWAY
EP1294513A4 (en) LOCALIZATION-SPECIFIC COVALENTS BIOKON JUGATION OF PROTEINS
FR2831769B1 (en) APPEARANCE FACTOR AND TASTEFAST
EP1424392A4 (en) NEW SECRETION PROTEINS AND RELATED DNA
ID24409A (en) STRUCTURE OF A BRIDGE BRIDGE
EP1637598A4 (en) PARTIAL PEPTIDE OF CD47 AND MONOCLONAL ANTIBODY ANTI-SHPS-1
EP1444245A4 (en) NOVEL CHROMOPHORES / FLUOROPHORES AND METHODS OF USE
EP1370579A4 (en) EXPRESSION OF A MATRIX GENE IN CHONDROGENESE
EP1088831A4 (en) NEW HEMOPO ETINE RECEPTOR PROTEINS
FR2824092B1 (en) SET OF CONSTRUCTION ELEMENTS
EP1464701A4 (en) FLUORESCENT PROTEINS
EP1456418A4 (en) IDENTIFICATION OF POLYMORPHIC SITES IN THE MGLUR8 HUMAN GENE AND USES THEREOF
EP1596803A4 (en) TRANSIENT PRODUCTION OF PHARMACEUTICALLY IMPORTANT PROTEINS IN PLANTS

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20041220

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1069460

Country of ref document: HK

DAX Request for extension of the european patent (deleted)
RIN1 Information on inventor provided before grant (corrected)

Inventor name: LIU, SHENGJIANG

Inventor name: CAO, YICHENG

Inventor name: WANG, CAILI

Inventor name: ZHONG, PINGYU

Inventor name: HSIEH, MARKMERCK & CO, INC

Inventor name: LUO, PEIZHIMERCK & CO, INC

A4 Supplementary search report drawn up and despatched

Effective date: 20091204

17Q First examination report despatched

Effective date: 20110221

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1069460

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20131203